Applying Multiple Tumor Models to Empower Cell Therapy Development
4:15 pm - Wednesday 29th July 2026
- Highlighting the rationale behind selecting and combining data from organoids and humanized mouse models
- Optimizing experimental variables to align with specific therapeutic objectives, from efficacy assessment to immune profiling for CAR-T
- Discussing scenarios for when to internalize or externalize model development, showcasing an example of glioblastoma model
